Small F

Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

2 papers · ORCID

ArticleDMT

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.

Marsden J, Kelleher M, Dunbar F +8

Europe PMC2025
ArticlePsilocybin

Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.

Piper T, Small F, Brown S +5

Europe PMC2025